On March 26, the US Supreme Court will hear oral arguments in a case that could severely restrict medication abortion access. Our experts break down key issues surrounding medication abortion, telemedicine and self-managed medication abortion. This analysis also explores relevant policy and research context, including current state policies, shield laws and the ongoing threat of criminalization for self-managed abortion.
Global Research & Policy
U.S. Research & Policy
Follow us on Instagram
The Guttmacher Institute's Board of Directors and acting CEO Jonathan Wittenberg are pleased to announce the appointment of Destiny Lopez as acting co-CEO.